EUSA Pharma has launched Rapydan (lidocaine, tetracaine), a medicated plaster for surface anaesthesia.

Rapydan contains 70mg lidocaine and 70mg tetracaine, and is indicated for surface anaesthesia for needle puncture in adults and children from three years of age, and for superficial surgical procedures on normal intact skin in adults.

The recommended dose is one or up to a maximum of four plasters for adults and one or up to a maximum of two plasters for children. The anaesthetic plasters must be applied 30 minutes before the procedure.

View Rapydan drug record

Further information: EUSA Pharma

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases